Skip to main content

Table 1 Clinicopathological characteristics of 142 patients

From: Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment

Characteristics

Total (nā€‰=ā€‰142)

Control (nā€‰=ā€‰71)

DC-CIK (nā€‰=ā€‰71)

p value

Sex, male/female

79/63

40/31

39/32

0.44

Age (years), meanā€‰Ā±ā€‰SD

55.4ā€‰Ā±ā€‰14.4

55.6ā€‰Ā±ā€‰14.3

55.3ā€‰Ā±ā€‰14.6

0.90

KPS, meanā€‰Ā±ā€‰SD

70.4ā€‰Ā±ā€‰6.3

70.1ā€‰Ā±ā€‰5.7

70.6ā€‰Ā±ā€‰6.8

0.79

Adenocarcinoma

ā€ƒWell differentiated

3

2

1

0.75

ā€ƒModerately differentiated

104

54

50

Ā 

ā€ƒPoorly differentiated

22

9

13

Ā 

ā€ƒUnknown

13

6

7

Ā 

TNM stage (III/IV)

98/54

41/30

47/24

0.27

FOLFIRI chemotherapy cycles

ā€ƒā‰¤ā€‰3

32

19

15

0.59

ā€ƒ4ā€“6

33

18

16

Ā 

ā€ƒ>ā€‰6

44

21

24

Ā 

Radiotherapy (yes/no)

49/93

22/49

27/44

0.31